FSD Pharma HUGE

$ 5.84 5743.5%

Annual report 2022
added 12-21-2024

FSD Pharma Balance Sheet 2011-2024 | HUGE

Annual Balance Sheet FSD Pharma

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-17 M	-5.88 M	-21.1 M	17.3 K	-9.34 K	23.9 K	-	-	-	-
Long Term Debt	-	-	-	147 K	-	-	-	-	-	-	-	-
Long Term Debt Current	178 K	124 K	46.8 K	40.9 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	79.1 K	147 K	-	-	-	-	-	-	-	-
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	7.87 M	8.83 M	5.66 M	9.23 M	1.74 M	113 K	80.4 K	80.2 K	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-90.9 M	-72.8 M	-26.5 M	-1.73 M	-1.7 M	-1.66 M	-	-	-	-
Total Assets	38.4 M	63 M	42 M	57.4 M	52.8 M	17.7 K	9.34 K	2.86 K	-	-	-	-
Cash and Cash Equivalents	17 M	35.3 M	17.5 M	5.97 M	15.9 M	-	-	-	-	-	-	-
Book Value	30.5 M	54.1 M	36.3 M	48.2 M	51 M	-95.5 K	-71.1 K	-77.3 K	-	-	-	-
Total Shareholders Equity	-	-	36.3 M	36.3 M	38.4 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet FSD Pharma

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	131 K	-	-	-	79.1 K	-	-	-	110 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	8.83 M	-	-	-	5.66 M	-	-	-	6.94 M	-	-	-	1.31 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-126 M	-	-	-	-90.9 M	-	-	-	-59.1 M	-	-	-	-19.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	-	63 M	-	-	-	42 M	-	-	-	43.2 M	-	-	-	39.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	-	35.3 M	-	-	-	17.5 M	-	-	-	5.97 M	-	-	-	15.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	-	54.1 M	-	-	-	36.3 M	-	-	-	36.3 M	-	-	-	38.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	-	54.1 M	-	-	-	36.3 M	-	-	-	36.3 M	-	-	-	38.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency